Search research articles
Contact Us
Filters
Showing results (411-420 of 776) with videos related to
Page
of 78
Sort By:
Brain : a Journal of Neurology
|
February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
Gaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Dementia and Geriatric Cognitive Disorders
|
March 11, 2011
Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study
Gobhathai Sittironnarit, David Ames, Ashley I Bush, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 22, 2005
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42
Peter J Crouch, Rachel Blake, James A Duce, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathology
Vincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Brain Communications
|
September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Samantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
The Journal of Biological Chemistry
|
December 19, 2007
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide
Paul S Donnelly, Aphrodite Caragounis, Tai Du, et al.
Alzheimer'S Research & Therapy
|
February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies
Michelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Alzheimer'S Research & Therapy
|
March 6, 2020
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
Sanka Amadoru, Vincent Doré, Catriona A McLean, et al.
Frontiers in Aging Neuroscience
|
December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
Samantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 19, 2023
The relationship between objective physical activity and change in cognitive function
Kelsey R Sewell, Stephanie R Rainey-Smith, Jeremiah Peiffer, et al.
Page
of 78
Search research articles
Search
Showing results (411-420 of 776) with videos related to
Sort By:
Page
of 78
Brain : a Journal of Neurology
|
February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
Gaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Dementia and Geriatric Cognitive Disorders
|
March 11, 2011
Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study
Gobhathai Sittironnarit, David Ames, Ashley I Bush, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 22, 2005
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42
Peter J Crouch, Rachel Blake, James A Duce, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathology
Vincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Brain Communications
|
September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Samantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
The Journal of Biological Chemistry
|
December 19, 2007
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide
Paul S Donnelly, Aphrodite Caragounis, Tai Du, et al.
Alzheimer'S Research & Therapy
|
February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies
Michelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Alzheimer'S Research & Therapy
|
March 6, 2020
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
Sanka Amadoru, Vincent Doré, Catriona A McLean, et al.
Frontiers in Aging Neuroscience
|
December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
Samantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 19, 2023
The relationship between objective physical activity and change in cognitive function
Kelsey R Sewell, Stephanie R Rainey-Smith, Jeremiah Peiffer, et al.
Page
of 78